Inhibition of Bile Acid Transport across Na+/Taurocholate Cotransporting Polypeptide (SLC10A1) and Bile Salt Export Pump (ABCB 11)-Coexpressing LLC-PK1 Cells by Cholestasis-Inducing Drugs

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Drug Metabolism And Disposition

• Publication date

  2006-09-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/dmd.105.008748PMID 16760228
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vectorial transport of unconjugated and conjugated bile salts by monolayers of LLC-PK1 cells doubly transfected with human NTCP and BSEP or with rat Ntcp and Bsep.

  2006cited by this paper
• Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11

  2005cited by this paper
• Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump.

  2005cited by this paper
• Expression and activities of several drug-metabolizing enzymes in LLC-PK1 cells.

  2004cited by this paper
• Drug- and chemical-induced cholestasis.

  2004cited by this paper
• Fluorescent Substrates of Sister-P-Glycoprotein (BSEP) Evaluated as Markers of Active Transport and Inhibition: Evidence for Contingent Unequal Binding Sites

  2003cited by this paper
• Bile salt transporters: molecular characterization, function, and regulation.

  2003cited by this paper
• Bile acid regulation of hepatic physiology: I. Hepatocyte transport of bile acids.

  2003cited by this paper
• Sinusoidal efflux of taurocholate correlates with the hepatic expression level of Mrp3.

  2002cited by this paper
• Mechanisms of Hepatic Transport of Drugs: Implications for Cholestatic Drug Reactions

  2002cited by this paper
• Bile salt transporters.

  2002cited by this paper
• Functional expression of the canalicular bile salt export pump of human liver.

  2002cited by this paper
• The human bile salt export pump: characterization of substrate specificity and identification of inhibitors.

  2002influential reference
• Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump.

  2001cited by this paper
• Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.

  2001cited by this paper
• MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells.

  2000cited by this paper
• Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2

  2000cited by this paper
• Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.

  2000cited by this paper
• Sulindac is excreted into bile by a canalicular bile salt pump and undergoes a cholehepatic circulation in rats.

  1999cited by this paper
• Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.

  1999cited by this paper
• Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells.

  1999cited by this paper
• Transport of fluorescent bile acids by the isolated perfused rat liver: Kinetics, sequestration, and mobilization

  1998cited by this paper
• The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver*

  1998cited by this paper
• A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis

  1998cited by this paper
• Substrate specificity of the rat liver Na+-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells.

  1998cited by this paper
• Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver

  1997cited by this paper
• Transport characteristics of three fluorescent conjugated bile acid analogs in isolated rat hepatocytes and couplets

  1995cited by this paper
• Expression and characterization of a functional rat liver Na+ bile acid cotransport system in COS-7 cells.

  1994cited by this paper
• Augmented expression of cytosolic phospholipase A2 during phenotypic transformation of cultured type II pneumocytes.

  1994cited by this paper
• Conjugated bile acid uptake by Xenopus laevis oocytes induced by microinjection with ileal Poly A+ mRNA.

  1992cited by this paper
• Chemical-induced interference with hepatocellular transport. Role in cholestasis.

  1991cited by this paper
• Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system.

  1991cited by this paper
• Cyclosporin A-induced cholestasis. The mechanism in a rat model.

  1987cited by this paper
• Secretion of bile acids by the liver and their role in the formation of hepatic bile.

  1972cited by this paper
• Canalicular bile production in dogs.

  1968cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Fluorescent dyes as functional probes for studying drug-transporting solute carriers

  2026cites this paper
• Fluorescent 4‑Nitrobenzo-2-oxa-1,3-diazole-Coupled Bile Acids as Probe Substrates of Hepatic and Intestinal Bile Acid Transporters of the Solute Carrier Families SLC10 and SLCO

  2025cites this paper
• A novel noninvasive test based on near-infrared fluorescent cholephilic probes for hepatobiliary secretory function assessment.

  2025cites this paper
• Contribution of Japanese scientists to drug metabolism and disposition.

  2025cites this paper
• Recent advancement in prevention against hepatotoxicity, molecular mechanisms, and bioavailability of gallic acid, a natural phenolic compound: challenges and perspectives

  2025cites this paper
• Human liver cell-based assays for the prediction of hepatic bile acid efflux transporter inhibition by drugs

  2025cites this paper
• Novel mechanism of Guizhi Jia Huangqi Decoction disrupting HBV lifecycle via cAMP/PKC/PKB axis beyond NTCP blockade.

  2025cites this paper
• Integrative multi-omics and causal inference unveil novel therapeutic targets for primary sclerosing cholangitis and its genetic comorbidity with inflammatory bowel disease

  2025cites this paper
• Synthesis, Characterization, and Potential Usefulness in Liver Function Assessment of Novel Bile Acid Derivatives with Near-Infrared Fluorescence (NIRBAD)

  2024cites this paper
• The role of botanical triterpenoids and steroids in bile acid metabolism, transport, and signaling: Pharmacological and toxicological implications

  2024cites this paper
• The Culprit Behind HBV-Infected Hepatocytes: NTCP

  2024cites this paper
• Cell-based BSEP trans-inhibition: A novel, non-invasive test for diagnosis of antibody-induced BSEP deficiency

  2023cites this paper
• Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.

  2023cites this paper
• Construction of extended and functional bile canaliculi using long-term sandwich-cultured cryopreserved human hepatocytes and the application of hepatocytes for predicting the biliary excretion of pharmaceutical and food-related compounds.

  2023cites this paper
• Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing

  2022cites this paper
• Structural insights into the HBV receptor and bile acid transporter NTCP

  2022cites this paper
• Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.

  2022cites this paper
• Bile acid indices as biomarkers for liver diseases I: Diagnostic markers

  2021cites this paper
• Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways.

  2021cites this paper
• Na+-Taurocholate Co-Transporting Polypeptide (NTCP) in Livers, Function, Expression Regulation, and Potential in Hepatitis B Treatment

  2021cites this paper
• Differentiation of Stem Cells into Hepatocyte Lineage: In Vitro Cell Culture, In Vivo Transplantation in Animal Models

  2021cites this paper
• Hepatic Bile Acid Transporters in Drug‐Induced Cholestasis

  2021cites this paper
• Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening

  2021cites this paper
• An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters

  2021cites this paper
• Compensatory Transition of Bile Acid Metabolism from Fecal Disposition of Secondary Bile Acids to Urinary Excretion of Primary Bile Acids Underlies Rifampicin-Induced Cholestasis in Beagle Dogs.

  2021cites this paper
• A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery

  2020cites this paper
• Assessment of Statin Interactions With the Human NTCP Transporter Using a Novel Fluorescence Assay

  2020cites this paper
• Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study

  2020cites this paper
• Basolateral Plasma Membrane Organic Anion Transporters

  2020cites this paper
• Role of Sodium Taurocholate Cotransporting Polypeptide as a New Reporter and Drug-Screening Platform: Implications for Preventing Hepatitis B Virus Infections

  2019cites this paper
• Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity.

  2019cites this paper
• Current insights in the complexities underlying drug-induced cholestasis

  2019cites this paper
• The Role of the Sodium-taurocholate Co-transporting Polypeptide (NTCP) and Bile Salt Export Pump (BSEP) in Related Liver Disease.

  2019cites this paper
• In Silico Approaches to Predict Drug-Transporter Interaction Profiles: Data Mining, Model Generation, and Link to Cholestasis.

  2019cites this paper
• Development of a mass spectrometric screening assay for hepatitis B virus entry inhibitors.

  2019cites this paper
• Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

  2019cites this paper
• Chemical Digestion, Absorption, and Transport

  2018cites this paper
• Inhibition of Glucose Transport by Tomatoside A, a Tomato Seed Steroidal Saponin, through the Suppression of GLUT2 Expression in Caco-2 Cells.

  2018cites this paper
• Comparing the performance of meta-classifiers—a case study on selected imbalanced data sets relevant for prediction of liver toxicity

  2018cites this paper
• Intravital Multiphoton Microscopy with Fluorescent Bile Salts in Rats as an In Vivo Biomarker for Hepatobiliary Transport Inhibition

  2018cites this paper
• TRANSPORTADORES CELULARES DE DROGAS. EL VIAJE DE LOS ANTIDIABÉTICOS ORALES POR EL ORGANISMO

  2018cites this paper
• Bile Salt Export Pump: Drug-Induced Liver Injury and Assessment Approaches

  2018cites this paper
• Preclinical Evaluation of [18F]LCATD as a PET Tracer to Study Drug-Drug Interactions Caused by Inhibition of Hepatic Transporters

  2018cites this paper
• The functional role of sodium taurocholate cotransporting polypeptide NTCP in the life cycle of hepatitis B, C and D viruses

  2018cites this paper
• Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures

  2018cites this paper
• Transporters in Hepatotoxicity

  2018cites this paper
• Predicting Drug-Induced Cholestasis with the Help of Hepatic Transporters—An in Silico Modeling Approach

  2017cites this paper
• Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes : Implications for Cellular Concentrations of Competing Drugs

  2017cites this paper
• Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.

  2017cites this paper
• Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response.

  2017cites this paper
• Using quantitative intravital multiphoton microscopy to dissect hepatic transport in rats.

  2017cites this paper
• Drug-Induced Liver Injury: Mechanism-Informed Prediction in Drug Development

  2017cites this paper
• Intrahepatic cholestasis: Molecular physiology of bile formation and secretion

  2017cites this paper
• Hepatic Clearance Prediction of Nine Human Immunodeficiency Virus Protease Inhibitors in Rat.

  2016cites this paper
• Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters.

  2016cites this paper
• Recent advances in the exploration of the bile salt export pump (BSEP/ABCB11) function

  2016cites this paper
• Transcytosis-Targeting Peptide: A Conductor of Liposomal Nanoparticles through the Endothelial Cell Barrier.

  2016cites this paper
• Translational research in tuberculosis: crossing barriers between molecular and clinical pharmacology

  2016influential citation
• Network-based Assessment on Chemical-induced Cholestatic Liver Injury.

  2016cites this paper
• Non-invasive visualisation and quantification of (disturbed) hepatobiliary transport

  2016cites this paper
• Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.

  2016cites this paper
• Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.

  2016cites this paper
• Membrane Transporters in Physiological Barriers of Pharmacological Importance.

  2016cites this paper
• Régulation de l'expression fonctionnelle de transporteurs membranaires dans des cellules hépatocytaires et pulmonaires exposées aux extraits de particules diesel

  2015cites this paper
• Rifampicin Induces Bicarbonate-Rich Choleresis in Rats: Involvement of Anion Exchanger 2

  2015cites this paper
• Ellagic acid: Pharmacological activities and molecular mechanisms involved in liver protection.

  2015cites this paper
• Nature and uses of fluorescent dyes for drug transporter studies

  2015cites this paper
• Analysis of Sinusoidal Drug Uptake Transporter Activities in Primary Human Hepatocytes.

  2015cites this paper
• Dehydroepiandrosterone sulfate, a useful endogenous probe for evaluation of drug-drug interaction on hepatic organic anion transporting polypeptide (OATP) in cynomolgus monkeys.

  2015cites this paper
• Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture.

  2015cites this paper
• Autoimmune liver diseases: internist's guide from bench to bedside

  2015cites this paper
• Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)

  2014cites this paper
• Current Concepts in Drug‐Induced Bile Salt Export Pump (BSEP) Interference

  2014influential citation
• Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition.

  2014cites this paper
• Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.

  2014cites this paper
• Classification of the Efficacy of Herbal Medicine Alterations in Neuronal Hypoxia Models through Analysis of Gene Expression

  2014cites this paper
• Hepatocytes maintain greater fluorescent bile acid accumulation and greater sensitivity to drug‐induced cell death in three‐dimensional matrix culture

  2014cites this paper
• Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.

  2014cites this paper
• Macitentan Does Not Interfere with Hepatic Bile Salt Transport

  2014cites this paper
• Enzyme-Transporter Interplay in the Formation and Clearance of Abundant Metabolites of Faldaprevir Found in Excreta but not in Circulation

  2014cites this paper
• Bridging In Vitro and In Vivo Metabolism and Transport of Faldaprevir in Human Using a Novel Cocultured Human Hepatocyte System, HepatoPac

  2014cites this paper
• Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs

  2013cites this paper
• Strategies for Minimisation of the Cholestatic Liver Injury Liability Posed by Drug- Induced Bile Salt Export Pump (BSEP) Inhibition

  2013cites this paper
• Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters

  2013cites this paper
• Evidence of drug-drug interactions through uptake and efflux transport systems in rat hepatocytes: implications for cellular concentrations of competing drugs

  2013cites this paper
• Development of Novel, 384-Well High-Throughput Assay Panels for Human Drug Transporters

  2013cites this paper
• In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions

  2013cites this paper
• Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters

  2013cites this paper
• Monitoring bile acid transport in single living cells using a genetically encoded Förster resonance energy transfer sensor

  2013cites this paper
• In Vivo Visualization and Quantification of (Disturbed) Oatp-Mediated Hepatic Uptake and Mrp2-Mediated Biliary Excretion of 99mTc-Mebrofenin in Mice

  2013cites this paper
• Hepatobiliary Disposition of 17-OHPC and Taurocholate in Fetal Human Hepatocytes: A Comparison with Adult Human Hepatocytes

  2013cites this paper
• DMD051193 1575..1583

  2013cites this paper
• Bile salt Export Pump BSEP (ABCB11): Role in liver physiology and liver disease

  2013cites this paper
• In silico identification of potential cholestasis-inducing agents via modeling of Na(+)-dependent taurocholate cotransporting polypeptide substrate specificity.

  2012cites this paper
• ERK1/2 and p38 MAPKs Are Complementarily Involved in Estradiol 17ß-d-Glucuronide-Induced Cholestasis: Crosstalk with cPKC and PI3K

  2012cites this paper
• Characterization of the Role of ABCG2 as a Bile Acid Transporter in Liver and Placenta

  2012cites this paper
• The SLC10 carrier family: transport functions and molecular structure.

  2012cites this paper
• Microsoft Word-17470528-file00

  2012cites this paper
• Automated Applications of Sandwich-Cultured Hepatocytes in the Evaluation of Hepatic Drug Transport

  2011cites this paper
• Effects of gender, and SLCO1B1 and CYP7A1 polymorphisms on plasma bile acids in humans and the pharmacokinetics of therapeutic ursodeoxycholic acid

  2011cites this paper